Sheri Wilcox

VP, Affinity Reagent Development at Nautilus Biotechnology

Sheri Wilcox currently serves as Vice President of Probe Development and Bioinformatics, as well as Vice President of Affinity Reagent Development at Nautilus Biotechnology since March 2022. Prior to this role, Sheri accumulated over two decades of experience at SomaLogic, where positions included Senior Director of Global Scientific Engagement and Senior Director of Analytical and Discovery Sciences, managing teams and leading discovery efforts in SOMAmer technology. Earlier roles included positions as Director and Associate Director of Discovery Sciences, and Scientist in Aptamer Discovery, where Sheri focused on advancing protocols and methods for biomarker discovery. Sheri began their career as a Postdoctoral Fellow at Pharmacia, working on mass spectrometric research. Academic credentials include a Ph.D. in Macromolecular and Cellular Structure and Chemistry from Scripps Research and a B.S. in Chemistry from Vanderbilt University.

Links

Previous companies

SomaLogic logo
Pfizer logo

Org chart